Empower Cells, Change Lives

AUSTIN, Texas, and HAMILTON, Ontario, January 29, 2019 - Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced that Dr. Paul Lammers, President & CEO, will...

AUSTIN, Texas & HAMILTON, Ontario & TORONTO – AUSTIN, Texas, and HAMILTON, Ontario, January 23, 2019 - Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today...

AUSTIN, Texas & HAMILTON, Ontario & TORONTO – Triumvira Immunologics Inc., announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the most important week for healthcare investors at the Hilton San Francisco Union...